cronos group glp-1 receptor agonists weight management diabetes treatments agonist GLP-1 For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1 receptor agonists in patients
Description
Ex vivo human placental transfer of the peptides pramlintide and exenatide (synthetic exendin-4)
doi:10.1210/jc.2010-2081 89
Prescribers should ensure that GLP-1 agonists are prescribed and administered properly, and that their patients receive adequate education and counseling regarding their potential effects
The benefit for diabetes therapy clearly is their indifference on bodyweight gain and the low risk of hypoglycemia
